CAT Posts Narrowed Revenue, Widened Loss in Q1 | GenomeWeb

NEW YORK, Feb. 25 - Cambridge Antibody Technology on Monday reported significantly widened loss in its first quarter 2002 atop slightly thinned revenue.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.